Annexon, Inc.
HUMANIZED ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF

Last updated:

Abstract:

The present disclosure is directed to humanized anti-C1q antibodies and methods of using them.

Status:
Application
Type:

Utility

Filling date:

8 Apr 2020

Issue date:

22 Apr 2021